Search

Your search keyword '"A. Calatroni"' showing total 69 results
Start Over Author "A. Calatroni" Publisher elsevier inc.
69 results on '"A. Calatroni"'

1. A pediatric randomized, controlled trial of German cockroach subcutaneous immunotherapy

Author

Zoratti, Edward, Wood, Robert, Pomés, Anna, Da Silva Antunes, Ricardo, Altman, Matthew C., Benson, Basilin, Wheatley, Lisa M., Cho, Kate, Calatroni, Agustin, Little, Frederic F., Pongracic, J., Makhija, Melanie, Khurana Hershey, Gurjit K., Sherenian, Michael G., Rivera-Spoljaric, Katherine, Stokes, Jeffrey R., Gill, Michelle A., Gruchalla, Rebecca S., Chambliss, Jeffrey, Liu, Andrew H., Kattan, Meyer, Busse, Paula J., Bacharier, Leonard B., Sheehan, William, Kim, Haejin., Glesner, Jill, Gergen, Peter J., Togias, Alkis, Baucom, Jessica L., Visness, Cynthia M., Sette, Alessandro, Busse, William W., and Jackson, Daniel J.

Published
2024
Full Text
View/download PDF

3. Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis

Author

Gatto, Mariele, Frontini, Giulia, Calatroni, Marta, Reggiani, Francesco, Depascale, Roberto, Cruciani, Claudio, Quaglini, Silvana, Sacchi, Lucia, Trezzi, Barbara, Bonelli, Grazia Dea, L'Imperio, Vincenzo, Vaglio, Augusto, Furlan, Claudia, Zen, Margherita, Iaccarino, Luca, Sinico, Renato Alberto, Doria, Andrea, and Moroni, Gabriella

Published
2024
Full Text
View/download PDF

4. Clinical and molecular analysis of longitudinal rhinitis phenotypes in an urban birth cohort

Author

Ramratnam, Sima K., Johnson, Molly, Visness, Cynthia M., Calatroni, Agustin, Altman, Mathew C., Janczyk, Tomasz, McCauley, Kathryn E., Schachtschneider, Claire, Fujimura, Kei E., Fadrosh, Douglas W., Lynch, Susan V., Bacharier, Leonard B., O'Connor, George T., Sandel, Megan T., Kattan, Meyer, Wood, Robert A., Gergen, Peter J., Jackson, Daniel J., Togias, Alkis, and Gern, James E.

Published
2024
Full Text
View/download PDF

6. Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment

Author

Simpson, Eric L., Schlievert, Patrick M., Yoshida, Takeshi, Lussier, Stephanie, Boguniewicz, Mark, Hata, Tissa, Fuxench, Zelma, De Benedetto, Anna, Ong, Peck Y., Ko, Justin, Calatroni, Agustin, Rudman Spergel, Amanda K., Plaut, Marshall, Quataert, Sally A., Kilgore, Samuel H., Peterson, Liam, Gill, Ann L., David, Gloria, Mosmann, Tim, Gill, Steven R., Leung, Donald Y.M., and Beck, Lisa A.

Published
2023
Full Text
View/download PDF

9. Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis

Author

Gatto, M, Frontini, G, Calatroni, M, Reggiani, F, Depascale, R, Cruciani, C, Quaglini, S, Sacchi, L, Trezzi, B, Bonelli, G, L'Imperio, V, Vaglio, A, Furlan, C, Zen, M, Iaccarino, L, Sinico, R, Doria, A, Moroni, G, Gatto M., Frontini G., Calatroni M., Reggiani F., Depascale R., Cruciani C., Quaglini S., Sacchi L., Trezzi B., Bonelli G. D., L'Imperio V., Vaglio A., Furlan C., Zen M., Iaccarino L., Sinico R. A., Doria A., Moroni G., Gatto, M, Frontini, G, Calatroni, M, Reggiani, F, Depascale, R, Cruciani, C, Quaglini, S, Sacchi, L, Trezzi, B, Bonelli, G, L'Imperio, V, Vaglio, A, Furlan, C, Zen, M, Iaccarino, L, Sinico, R, Doria, A, Moroni, G, Gatto M., Frontini G., Calatroni M., Reggiani F., Depascale R., Cruciani C., Quaglini S., Sacchi L., Trezzi B., Bonelli G. D., L'Imperio V., Vaglio A., Furlan C., Zen M., Iaccarino L., Sinico R. A., Doria A., and Moroni G.

Abstract

Introduction: This retrospective study on patients with biopsy-proven lupus nephritis (LN) aimed to assess the probability of sustained clinical remission (sCR) and to investigate sCR effects on disease flares and impaired kidney function (IKF). Methods: sCR was defined as clinical-Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) = 0 and estimated glomerular filtration rate (eGFR) >60 ml/min per 1.73 m2 lasting ≥1 year; IKF: eGFR <60 ml/min per 1.73 m2 for >3 months. We analyzed the probability of achieving and maintaining sCR, and the yearly risk of flare. Cox models were used to identify predictors of sCR and IKF with variables analyzed as time-dependent covariates when appropriate. Results: Of 303 patients followed-up with for 14.8 (interquartile range: 9.8–22) years, 257 (84.8%) achieved sCR. The probability of achieving sCR progressively increased over time reaching 90% at 15 years. Baseline age (hazard ratio [HR]: 1.017; 95% confidence interval [CI]: 0.005–1.029; P = 0.004), hydroxychloroquine intake (HR: 1.385; 95% CI: 1.051–1.825; P = 0.021), and absence of arterial hypertension (HR: 0.699; 95% CI: 0.532–0.921; P = 0.011) were independent predictors of sCR. Among patients who achieved sCR, 142 (55.3%) developed a lupus flare after a median time of 3.6 (2.3–5.9) years. In the remaining 115 patients, sCR persisted for 9.5 (5.8–14.5) years. The probability of sCR to persist at 15 years was 38%. SLE flare risk decreased to 10%, 5%, and 2% in patients with sCR lasting <5, 5 to 10, and >10 years, respectively. At the last observation, 57 patients (18.81%) had IKF. sCR achievement (HR: 0.18, P < 0.001) and its duration (HR: 0.83, P < 0.001) were protective against IKF. Conclusion: sCR is an achievable target in LN management and protects against IKF. The longer the sCR, the higher the chance of its persistence and the lower the risk of SLE flares.

Published
2024

10. The SunBEAm birth cohort: Protocol design

Author

Keet, Corinne, Sicherer, Scott H., Bunyavanich, Supinda, Visness, Cynthia, Fulkerson, Patricia C., Togias, Alkis, Davidson, Wendy, Perry, Susan, Hamrah, Sanaz, Calatroni, Agustin, Robinson, Katina, Dunaway, Lars, Davis, Carla M., Anvari, Sara, Leong-Kee, Susan M., Hershey, Gurjit Khurana, DeFranco, Emily, Devonshire, Ashley, Kim, Haejin, Joseph, Christine, Davidson, Brent, Strong, Noel K., Tsuang, Angela J., Groetch, Marion, Wang, Julie, Dantzer, Jennifer, Mudd, Kim, Aina, Abimbola, Shreffler, Wayne, Yuan, Qian, Simmons, Virginia, Leung, Donald Y.M., Hui-Beckman, Jessica, Ramos, Jania Arcia, Chinthrajah, Sharon, Winn, Virginia, Sindher, Tina, Jones, Stacie M., Manning, Nirvana A., Scurlock, Amy M., Kim, Edwin, Stuebe, Alison, Gern, James E., Singh, Anne Marie, Krupp, Jennifer, and Wood, Robert A.

Published
2023
Full Text
View/download PDF

11. The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult

Author

Affatato, Stefania, Caroti, Leonardo, Mancini, Elena, Semeraro, Luca, Siligato, Rossella, Arnaldo Cassia, Matthias, Napodano, Pietro, Calatroni, Marta, Distratis, Cosimo, Campo, Andrea, Tedesco, Martina, Mescia, Federica, Pisani, Isabella, Allinovi, Marco, Casazza, Giovanni, Del Vecchio, Lucia, Santostefano, Marisa, Cirillo, Luigi, Ferrario, Francesca, Esposito, Ciro, Esposito, Pasquale, Santoro, Domenico, Lazzarin, Roberta, Rossi, Giovanni Maria, Fiaccadori, Enrico, Ferrantelli, Angelo, Sinico, Renato Alberto, Cozzolino, Mario, Gallieni, Maurizio, Cirami, Lino, Scolari, Francesco, Vaglio, Augusto, and Alberici, Federico

Published
2022
Full Text
View/download PDF

14. Aeroallergen Sensitization, Serum IgE, and Eosinophilia as Predictors of Response to Omalizumab Therapy During the Fall Season Among Children with Persistent Asthma

Author

Sheehan, William J., Krouse, Rebecca Z., Calatroni, Agustin, Gergen, Peter J., Gern, James E., Gill, Michelle A., Gruchalla, Rebecca S., Khurana Hershey, Gurjit K., Kattan, Meyer, Kercsmar, Carolyn M., Lamm, Carin I., Little, Frederic F., Makhija, Melanie M., Searing, Daniel A., Zoratti, Edward, Busse, William W., and Teach, Stephen J.

Published
2020
Full Text
View/download PDF

15. Changing Phenotypes and Clinical Outcomes Over Time in Microscopic Polyangiitis

Author

Uzzo, M, Maggiore, U, Sala, F, Reggiani, F, L'Imperio, V, Deliso, F, Calatroni, M, Moroni, G, Sinico, R, Uzzo M., Maggiore U., Sala F., Reggiani F., L'Imperio V., Deliso F., Calatroni M., Moroni G., Sinico R. A., Uzzo, M, Maggiore, U, Sala, F, Reggiani, F, L'Imperio, V, Deliso, F, Calatroni, M, Moroni, G, Sinico, R, Uzzo M., Maggiore U., Sala F., Reggiani F., L'Imperio V., Deliso F., Calatroni M., Moroni G., and Sinico R. A.

Abstract

Introduction: Diagnosis and management of microscopic polyangiitis (MPA) have evolved considerably over the past decades, but it is unknown whether clinical and histological presentation and patient and renal outcomes have changed accordingly. Methods: We compared clinical and histopathological characteristic at diagnosis, risk of death, end-stage kidney disease (ESKD), and relapse rate in patients diagnosed with MPA between 1980 and 2022, after grouping them in 2 periods (p): p1980-2001 and p2002-2022. We compared the mortality rate between the 2 periods using Kaplan-Meier estimator and Cox-regression, and competing risks of ESKD and death using the Aalen-Johansen estimator, Fine-Gray multiple regression, and multistate models. Results: Out of 187 patients, 77 were in p1980-2001 and 110 in p2002 to 2022. Patients in p2002 to 2022 were older (66.2 ± 14.0 SD vs. 57.7 ± 15.8; P < 0.001), had a better kidney function (estimated glomerular filtration rate [eGFR] 25.9 ± 24.8 vs. 21.5 ± 28.2 ml/min per 1.73 m2; P = 0.011) and a lower prevalence of the Berden sclerotic class (5.9 vs. 20.9%; P = 0.011). Despite a similar crude and adjusted patient survival, the risk of ESKD decreased during p2002 to 2022 (subdistribution hazard ratio [HR] 0.30, 95% confidence interval [CI]: 0.16-0.57; P < 0.001). The results remained significant after accounting for death after ESKD and after adjusting for potential confounders (HR 0.33 [95% CI: 0.18-0.63; P < 0.001]). The risk of relapse was numerically higher during p2002 to 2022 (subdistribution-HR 1.64 [95% CI: 0.95-2.83; P = 0.075]). Conclusion: MPA kidney involvement has become less severe over the past decades, leading to a reduced risk of ESKD and a higher relapse rate, despite a comparable risk of death.

Published
2023

17. Distinct nasal airway bacterial microbiotas differentially relate to exacerbation in pediatric patients with asthma

Author

McCauley, Kathryn, Durack, Juliana, Valladares, Ricardo, Fadrosh, Douglas W., Lin, Din L., Calatroni, Agustin, LeBeau, Petra K., Tran, Hoang T., Fujimura, Kei E., LaMere, Brandon, Merana, Geil, Lynch, Kole, Cohen, Robyn T., Pongracic, Jacqueline, Khurana Hershey, Gurjit K., Kercsmar, Carolyn M., Gill, Michelle, Liu, Andrew H., Kim, Haejin, Kattan, Meyer, Teach, Stephen J., Togias, Alkis, Boushey, Homer A., Gern, James E., Jackson, Daniel J., and Lynch, Susan V.

Published
2019
Full Text
View/download PDF

23. The Role of Rituximab in Primary Focal Segmental Glomerulosclerosis of the Adult

Author

Tedesco, M, Mescia, F, Pisani, I, Allinovi, M, Casazza, G, Del Vecchio, L, Santostefano, M, Cirillo, L, Ferrario, F, Esposito, C, Esposito, P, Santoro, D, Lazzarin, R, Rossi, G, Fiaccadori, E, Ferrantelli, A, Sinico, R, Cozzolino, M, Gallieni, M, Cirami, L, Scolari, F, Vaglio, A, Alberici, F, Affatato, S, Caroti, L, Mancini, E, Semeraro, L, Siligato, R, Cassia, M, Napodano, P, Calatroni, M, Distratis, C, Campo, A, Tedesco, Martina, Mescia, Federica, Pisani, Isabella, Allinovi, Marco, Casazza, Giovanni, Del Vecchio, Lucia, Santostefano, Marisa, Cirillo, Luigi, Ferrario, Francesca, Esposito, Ciro, Esposito, Pasquale, Santoro, Domenico, Lazzarin, Roberta, Rossi, Giovanni Maria, Fiaccadori, Enrico, Ferrantelli, Angelo, Sinico, Renato Alberto, Cozzolino, Mario, Gallieni, Maurizio, Cirami, Lino, Scolari, Francesco, Vaglio, Augusto, Alberici, Federico, Affatato, Stefania, Caroti, Leonardo, Mancini, Elena, Semeraro, Luca, Siligato, Rossella, Cassia, Matthias Arnaldo, Napodano, Pietro, Calatroni, Marta, Distratis, Cosimo, Campo, Andrea, Tedesco, M, Mescia, F, Pisani, I, Allinovi, M, Casazza, G, Del Vecchio, L, Santostefano, M, Cirillo, L, Ferrario, F, Esposito, C, Esposito, P, Santoro, D, Lazzarin, R, Rossi, G, Fiaccadori, E, Ferrantelli, A, Sinico, R, Cozzolino, M, Gallieni, M, Cirami, L, Scolari, F, Vaglio, A, Alberici, F, Affatato, S, Caroti, L, Mancini, E, Semeraro, L, Siligato, R, Cassia, M, Napodano, P, Calatroni, M, Distratis, C, Campo, A, Tedesco, Martina, Mescia, Federica, Pisani, Isabella, Allinovi, Marco, Casazza, Giovanni, Del Vecchio, Lucia, Santostefano, Marisa, Cirillo, Luigi, Ferrario, Francesca, Esposito, Ciro, Esposito, Pasquale, Santoro, Domenico, Lazzarin, Roberta, Rossi, Giovanni Maria, Fiaccadori, Enrico, Ferrantelli, Angelo, Sinico, Renato Alberto, Cozzolino, Mario, Gallieni, Maurizio, Cirami, Lino, Scolari, Francesco, Vaglio, Augusto, Alberici, Federico, Affatato, Stefania, Caroti, Leonardo, Mancini, Elena, Semeraro, Luca, Siligato, Rossella, Cassia, Matthias Arnaldo, Napodano, Pietro, Calatroni, Marta, Distratis, Cosimo, and Campo, Andrea

Abstract

Introduction: Primary focal segmental glomerular sclerosis (FSGS) is a rare, likely immune-mediated disease. Rituximab (RTX) may play a role in management, although data in adults are scanty. Methods: We collected cases of RTX-treated primary FSGS within the Italian Society of Nephrology Immunopathology Working Group and explored response rate (24-hour proteinuria <3.5 g and <50% compared with baseline, stable estimated glomerular filtration rate). Results: A total of 31 patients were followed for at least 12 months; further follow-up (median 17 months, interquartile range [IQR] 15–33.5) was available for 11. At first RTX administration, median creatinine and 24-hour proteinuria were 1.17 mg/dl (IQR 0.83–1.62) and 5.2 g (IQR 3.3–8.81), respectively. Response rate at 3, 6, and 12 months was 39%, 52%, and 42%, respectively. In the first 12 months, creatinine level remained stable whereas proteinuria and serum albumin level improved, with an increase in the proportion of patients tapering other immunosuppressants. There were 6 patients who were retreated with RTX within 12 months, either for proteinuria increase or refractory disease; only the 2 responders to the first RTX course experienced a further response. At univariate analysis, 6-month response was more frequent in steroid-dependent patients (odds ratio [OR] 7.7 [95% CI 1.16–52.17]) and those with proteinuria <5 g/24 h (OR 8.25 [1.45–46.86]). During long-term follow-up, 4 of 5 responders at 12 months maintained a sustained response, either without further immunosuppression (2 of 4) or with pre-emptive RTX (2 of 4); 1 relapsed and responded to RTX retreatment. Conclusion: RTX may be an option in primary FSGS, especially in steroid-dependent patients, with 24-hour proteinuria <5 g and previously responders to RTX. Optimal long-term management for responders is unclear, with some patients experiencing sustained remission and others requiring RTX retreatment, either preemptive or after rising proteinuria

Published
2022

25. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations

Author

Teach, Stephen J., Gill, Michelle A., Togias, Alkis, Sorkness, Christine A., Arbes, Samuel J., Jr., Calatroni, Agustin, Wildfire, Jeremy J., Gergen, Peter J., Cohen, Robyn T., Pongracic, Jacqueline A., Kercsmar, Carolyn M., Khurana Hershey, Gurjit K., Gruchalla, Rebecca S., Liu, Andrew H., Zoratti, Edward M., Kattan, Meyer, Grindle, Kristine A., Gern, James E., Busse, William W., and Szefler, Stanley J.

Published
2015
Full Text
View/download PDF

27. DNA methylation and childhood asthma in the inner city

Author

Yang, Ivana V., Pedersen, Brent S., Liu, Andrew, O'Connor, George T., Teach, Stephen J., Kattan, Meyer, Misiak, Rana Tawil, Gruchalla, Rebecca, Steinbach, Suzanne F., Szefler, Stanley J., Gill, Michelle A., Calatroni, Agustin, David, Gloria, Hennessy, Corinne E., Davidson, Elizabeth J., Zhang, Weiming, Gergen, Peter, Togias, Alkis, Busse, William W., and Schwartz, David A.

Published
2015
Full Text
View/download PDF

29. Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children

Author

Lynch, Susan V., Wood, Robert A., Boushey, Homer, Bacharier, Leonard B., Bloomberg, Gordon R., Kattan, Meyer, O’Connor, George T., Sandel, Megan T., Calatroni, Agustin, Matsui, Elizabeth, Johnson, Christine C., Lynn, Henry, Visness, Cynthia M., Jaffee, Katy F., Gergen, Peter J., Gold, Diane R., Wright, Rosalind J., Fujimura, Kei, Rauch, Marcus, Busse, William W., and Gern, James E.

Published
2014
Full Text
View/download PDF

34. Corrigendum to “Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis” [Kidney International Reports Volume 9, Issue 4, April 2024, Pages 1047–1056]

Author

Gatto, Mariele, Frontini, Giulia, Calatroni, Marta, Reggiani, Francesco, Depascale, Roberto, Cruciani, Claudio, Quaglini, Silvana, Sacchi, Lucia, Trezzi, Barbara, Bonelli, Grazia Dea, L’Imperio, Vincenzo, Vaglio, Augusto, Furlan, Claudia, Zen, Margherita, Iaccarino, Luca, Sinico, Renato Alberto, Doria, Andrea, and Moroni, Gabriella

Published
2024
Full Text
View/download PDF

37. Serum IL-6: A biomarker in childhood asthma?

Author

Jackson, Daniel J., Bacharier, Leonard B., Calatroni, Agustin, Gill, Michelle A., Hu, Jack, Liu, Andrew H., Wheatley, Lisa M., Gern, James E., Gruchalla, Rebecca S., Khurana Hershey, Gurjit K., Kattan, Meyer, Kercsmar, Carolyn M., Kim, Haejin, O’Connor, George T., Patel, Shilpa, Pongracic, Jacqueline A., Wood, Robert A., and Busse, William W.

Published
2020
Full Text
View/download PDF

41. Down-Modulation of Cockroach (CR) Allergen-specific Th2 Cell Responses Following Subcutaneous German Cockroach Allergen Immunotherapy (SCIT)

Author

Da Silva Antunes, Ricardo, Frazier, April, Pomés, Anna, Calatroni, Augustin, Wood, Robert, O'Connor, George, Pongracic, Jacqueline, Hershey, Gurjit Khurana, Kercsmar, Carolyn, Gill, Michelle, Liu, Andrew, Zoratti, Edward, Kattan, Meyer, Busse, Paula, Bacharier, Leonard, Teach, Stephen, Wheatley, Lisa, Togias, Alkis, Busse, William, Jackson, Daniel, and Sette, Alessandro

Published
2023
Full Text
View/download PDF

42. The Effect of Subcutaneous German Cockroach Immunotherapy (SCIT) on Nasal Allergen Challenge (NAC) and Cockroach-specific Antibody Responses Among Urban Children and Adolescents

Author

Zoratti, Edward, Wood, Robert, O, George, Pongracic, Jacqueline, Makhija, Melanie, Hershey, Gurjit Khurana, Sherenian, Michael, Gill, Michelle, Gruchalla, Rebecca, Chambliss, Jeffrey, Liu, Andrew, Kattan, Meyer, Busse, Paula, Bacharier, Leonard, Rivera-Spoljaric, Katherine, Sheehan, William, Jackson, Daniel, Gergen, Peter, Togias, Alkis, Calatroni, Agustin, Visness, Cynthia, Cho, Kate, Sette, Alessandro, Altman, Matthew, and Busse, William

Published
2023
Full Text
View/download PDF

43. Epithelial-Associated Inflammatory Pathways Underlie Residual Asthma Exacerbations in Urban Children Treated with Mepolizumab Therapy

Author

Patel, Sana, Altman, Matthew, Cox, Madison, Bacharier, Leonard, Calatroni, Agustin, Gill, Michelle, Stokes, Jeffrey, Liu, Andrew, Cohen, Robyn, Makhija, Melanie, Hershey, Gurjit Khurana, O’Connor, George, Zoratti, Edward, Teach, Stephen, Kattan, Meyer, Becker, Patrice, Togias, Alkis, Busse, William, and Jackson, Daniel

Published
2023
Full Text
View/download PDF

44. Mepolizumab Alters Regulation of Airway Type-2 Inflammation in Urban Children with Asthma by Disrupting Eosinophil Gene Expression but Enhancing Mast Cell and Epithelial Pathways

Author

Gaberino, Courtney, Segnitz, R. Max, Cox, Madison, Bacharier, Leonard, Calatroni, Agustin, Gill, Michelle, Stokes, Jeffrey, Liu, Andrew, Cohen, Robyn, Makhija, Melanie, Hershey, Gurjit Khurana, O'Connor, George, Zoratti, Edward, Teach, Stephen, Kattan, Meyer, Becker, Patrice, Togias, Alkis, Busse, William, Jackson, Daniel, and Altman, Matthew

Published
2023
Full Text
View/download PDF

46. ABL1 amplification in T-cell acute lymphoblastic leukemia

Author

Bernasconi, Paolo, Calatroni, Silvia, Giardini, Ilaria, Inzoli, Alessandro, Castagnola, Carlo, Cavigliano, Paola Maria, Rocca, Barbara, Boni, Marina, Quarna, Jessica, Zappatore, Rita, Caresana, Marilena, Bianchessi, Clara, Pallavicini, Enrico Bobbio, and Lazzarino, Mario

Published
2005
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results